Literature DB >> 25777059

Strategies to engineer tendon/ligament-to-bone interface: Biomaterials, cells and growth factors.

Sonia Font Tellado1, Elizabeth R Balmayor2, Martijn Van Griensven2.   

Abstract

Integration between tendon/ligament and bone occurs through a specialized tissue interface called enthesis. The complex and heterogeneous structure of the enthesis is essential to ensure smooth mechanical stress transfer between bone and soft tissues. Following injury, the interface is not regenerated, resulting in high rupture recurrence rates. Tissue engineering is a promising strategy for the regeneration of a functional enthesis. However, the complex structural and cellular composition of the native interface makes enthesis tissue engineering particularly challenging. Thus, it is likely that a combination of biomaterials and cells stimulated with appropriate biochemical and mechanical cues will be needed. The objective of this review is to describe the current state-of-the-art, challenges and future directions in the field of enthesis tissue engineering focusing on four key parameters: (1) scaffold and biomaterials, (2) cells, (3) growth factors and (4) mechanical stimuli.
Copyright © 2015 Elsevier B.V. All rights reserved.

Keywords:  Bone; Enthesis; Interface; Ligament; Tendon; Tissue engineering

Mesh:

Substances:

Year:  2015        PMID: 25777059     DOI: 10.1016/j.addr.2015.03.004

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  53 in total

Review 1.  [Biomaterials in orthopedics].

Authors:  S Vogt; T Tischer; F Blanke
Journal:  Orthopade       Date:  2015-08       Impact factor: 1.087

2.  Meniscus Repair and Regeneration: A Systematic Review from a Basic and Translational Science Perspective.

Authors:  John Twomey-Kozak; Chathuraka T Jayasuriya
Journal:  Clin Sports Med       Date:  2020-01       Impact factor: 2.182

3.  Rheological Analysis of the Gelation Kinetics of an Enzyme Cross-linked PEG Hydrogel.

Authors:  Raul Sun Han Chang; Johnny Ching-Wei Lee; Sara Pedron; Brendan A C Harley; Simon A Rogers
Journal:  Biomacromolecules       Date:  2019-05-10       Impact factor: 6.988

4.  Functionally graded biomaterials for use as model systems and replacement tissues.

Authors:  Jeremy M Lowen; J Kent Leach
Journal:  Adv Funct Mater       Date:  2020-03-04       Impact factor: 18.808

5.  Bi-directional modulation of cellular interactions in an in vitro co-culture model of tendon-to-bone interface.

Authors:  I Calejo; Raquel Costa-Almeida; Ana Isabel Gonçalves; Dominika Berdecka; Rui Luis Reis; Manuela Estima Gomes
Journal:  Cell Prolif       Date:  2018-08-14       Impact factor: 6.831

6.  Effect of scaffold morphology and cell co-culture on tenogenic differentiation of HADMSC on centrifugal melt electrospun poly (L‑lactic acid) fibrous meshes.

Authors:  Shaohua Wu; Hao Peng; Xiuhong Li; Philipp N Streubel; Yong Liu; Bin Duan
Journal:  Biofabrication       Date:  2017-11-14       Impact factor: 9.954

7.  Tunable tissue scaffolds fabricated by in situ crosslink in phase separation system.

Authors:  Xifeng Liu; Wenjian Chen; Carl T Gustafson; A Lee Miller; Brian E Waletzki; Michael J Yaszemski; Lichun Lu
Journal:  RSC Adv       Date:  2015-11-18       Impact factor: 3.361

8.  Analysis of early cellular responses of anterior cruciate ligament fibroblasts seeded on different molecular weight polycaprolactone films functionalized by a bioactive poly(sodium styrene sulfonate) polymer.

Authors:  Amélie Leroux; Jagadeesh K Venkatesan; David G Castner; Magali Cucchiarini; Véronique Migonney
Journal:  Biointerphases       Date:  2019-08-12       Impact factor: 2.456

9.  Current Status of Tissue-Engineered Scaffolds for Rotator Cuff Repair.

Authors:  Abby Chainani; Dianne Little
Journal:  Tech Orthop       Date:  2016-06

10.  Next Generation Tissue Engineering of Orthopedic Soft Tissue-to-Bone Interfaces.

Authors:  Alexander J Boys; Mary Clare McCorry; Scott Rodeo; Lawrence J Bonassar; Lara A Estroff
Journal:  MRS Commun       Date:  2017-10-03       Impact factor: 2.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.